Skip to content
TGA: interim scheduling decisions (Australia)·AI score58

TGA publishes interim decisions on proposed Poisons Standard amendments from ACCS #40 and Joint ACMS-ACCS #39

Notice of interim decisions on proposed amendments to the Poisons Standard - ACCS #40 and Joint ACMS-ACCS #39 - March 2025

AI summary

The TGAThe Therapeutic Goods Administration, Australia's national regulator of medicines and medical devices.Open the glossary has published interim decisions on proposed amendments to the Poisons StandardThe Australian legal instrument that sorts medicines and chemicals into schedules, which set how each can be supplied.Open the glossary arising from the Advisory Committee on Chemicals Scheduling (ACCS) #40 and the Joint Advisory Committee on Medicines Scheduling and Advisory Committee on Chemicals Scheduling (Joint ACMS-ACCS) #39. The notice invites comment, with a closing date of 23 January 2026. The feed gave no further detail on which substances or schedules the interim decisions cover.

Key facts

Compounds
Psilocybin, MDMA
Jurisdiction
Australia
Source
TGA: interim scheduling decisions (Australia) (tga.gov.au)
Published
How this summary was made

The summary was written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method

Source: TGA: interim scheduling decisions (Australia) · tga.gov.au

Connected to

Jurisdiction
Australia

Other recent items on these topics